Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+channel blocker and a Ca2+channel agonist-Reference-Cited by-同舟云学术

Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+channel blocker and a Ca2+channel agonist

Author:

Tarr Tyler B.¹²,Lacomis David³⁴,Reddel Stephen W.⁵,Liang Mary⁶⁷,Valdomir Guillermo⁶⁷,Frasso Michael⁶⁷,Wipf Peter⁶⁷,Meriney Stephen D.¹²

Affiliation:

1. Department of Neuroscience, Center for Neuroscience; University of Pittsburgh; Pittsburgh PA USA

2. Center for the Neural Basis of Cognition; University of Pittsburgh; Pittsburgh PA USA

3. Division of Neuromuscular Diseases, Department of Neurology; University of Pittsburgh; Pittsburgh PA USA

4. Department of Pathology; University of Pittsburgh; Pittsburgh PA USA

5. Department of Clinical Neurology; Concord Hospital; Sydney NSW Australia

6. Department of Chemistry; University of Pittsburgh; Pittsburgh PA USA

7. Center for Chemical Methodologies and Library Development; University of Pittsburgh; Pittsburgh PA USA

Funder

Achievement Rewards for College Scientists (ARCS)

National Science Foundation

National Institutes of Health

Muscular Dystrophy Association

Myasthenia Associations of Australia and the Beeren Foundation

University of Pittsburgh Central Research Development Fund

Publisher

Wiley

Subject

Physiology

Link

Reference38 articles.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lambert-Eaton myasthenic syndrome;Handbook of Clinical Neurology;2024